System, apparatus and method for sensing, detecting and effecting in a micro-to-nano environment

Abstract

An apparatus that is [mu]m- or nm- scale in size and can include integrated circuitry logic based on sub 10 nm SIA transistor nodes, a sensing subsystem, a deciding subsystem, an effecting subsystem, and a power harvesting system is described. The sensing subsystem can identify pathogenic entities, including disease associated cells (for example, cancer cells, autoimmune cells, or pathological microbes) or viruses. The sensing subsystem can include at least one pad constructed of an electrically conductive material and linkers attached to the at least one pad. Each linker can also be attached to a targeting agent (for example, an antibody fragment) or a reference agent. Upon the binding of a targeting agent with an entity of interest, the information is transferred to the logic circuitry, which processes the binding event information and decides whether the entity is disease associated (e.g., a disease associated cell or virus) and requires delivery of therapeutic agents or other treatment.

Description

[0001] Cross-reference related application [0002] This application claims priority to co-pending US provisional patent on April 8, 2019 filed 62 equity / number of 830,762, is hereby incorporated by reference in its entirety. Technical field [0003] The present invention relates to a therapeutic or medical nano robots, nano means comprises a sensing and identification of chemical and biological materials and dispensing targeting therapeutic agents and other chemicals or micro-device. Background technique [0004] Including disease-related cells ( "DAC") and pathogenic disease-causing virus in a wide range of entities and the main reason is the root cause of the pathological mechanisms of disease morbidity and mortality. Such diseases include, but are not limited to, cancer, autoimmune diseases and infectious diseases (including by viruses, parasites, bacteria that cause). In 2019, only about 600,000 US cancer has led to deaths, an estimated 1.8 million new cancer diagnoses. In...

AI Technical Summary

Problems solved by technology

[0005] A major reason for the lack of progress in the development of effective and established therapeutics targeting disease-causing entities (including DACs, parasites, viruses, and others) is the inherent adaptation of these disease-causing entities and the development of resistance mechanisms that render many therapeutics ineffective Ability

Images